Pfizer gets US antitrust clearance for Metsera deal
31/10/2025 19:53
Oct 31 (Reuters) - Pfizer PFE.N said on Friday it has received an early clearance from the U.S. Federal Trade Commission for its proposed acquisition of Metsera MTSR.O. (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up